Stifel Financial
VKTX icon

Stifel Financial’s Viking Therapeutics VKTX Stock Holding History

Stifel Financial’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Buy
340,521
+3,701
+1% +$119K 0.01% 898
2025
Q4 		$11.8M Sell
336,820
-13,547
-4% -$480K 0.01% 872
2025
Q3 		$9.21M Sell
350,367
-26,081
-7% -$778K 0.01% 989
2025
Q2 		$9.98M Buy
376,448
+22,998
+7% +$605K 0.01% 882
2025
Q1 		$8.54M Buy
353,450
+174,631
+98% +$5.52M 0.01% 908
2024
Q4 		$7.2M Buy
178,819
+47,471
+36% +$2.71M 0.01% 1013
2024
Q3 		$8.32M Buy
131,348
+62,956
+92% +$3.69M 0.01% 924
2024
Q2 		$3.63M Buy
68,392
+44,511
+186% +$2.92M ﹤0.01% 1326
2024
Q1 		$1.96M Buy
23,881
+13,644
+133% +$607K ﹤0.01% 1736
2023
Q4 		$191K Buy
+10,237
New +$134K ﹤0.01% 3070
2021
Q4 		– Sell
-20,766
Closed -$130K – 3475
2021
Q3 		$130K Sell
20,766
-100
-0.5% -$618 ﹤0.01% 3210
2021
Q2 		$125K Sell
20,866
-9,442
-31% -$56.1K ﹤0.01% 3214
2021
Q1 		$192K Buy
30,308
+10,676
+54% +$75.1K ﹤0.01% 3028
2020
Q4 		$111K Sell
19,632
-782
-4% -$4.74K ﹤0.01% 2927
2020
Q3 		$119K Buy
20,414
+689
+3% +$4.74K ﹤0.01% 2732
2020
Q2 		$142K Sell
19,725
-1,142
-5% -$7.58K ﹤0.01% 2661
2020
Q1 		$99K Sell
20,867
-13,987
-40% -$86K ﹤0.01% 2592
2019
Q4 		$290K Buy
34,854
+12,991
+59% +$94.7K ﹤0.01% 2547
2019
Q3 		$162K Sell
21,863
-330
-1% -$2.45K ﹤0.01% 2693
2019
Q2 		$189K Sell
22,193
-623
-3% -$5.32K ﹤0.01% 2731
2019
Q1 		$233K Buy
22,816
+502
+2% +$4.2K ﹤0.01% 2518
2018
Q4 		$176K Buy
22,314
+5,237
+31% +$62.6K ﹤0.01% 2485
2018
Q3 		$298K Sell
17,077
-9,978
-37% -$119K ﹤0.01% 2363
2018
Q2 		$258K Buy
+27,055
New +$180K ﹤0.01% 2394

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Stifel Financial's VKTX Position: Q1 2026 in Review

Stifel Financial increased its Viking Therapeutics (VKTX) stake by 1.1% in Q1 2026, buying an estimated $119K and bringing the position to 340,521 shares worth $11.1M. The position accounts for 0.01% of the portfolio, ranked #898.

Stifel Financial first reported a position in VKTX in Q2 2018 and has held it in 24 quarters since. The position peaked at $11.8M in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Stifel Financial held 340,521 shares of Viking Therapeutics worth $11.1M as of Q1 2026.
  • Stifel Financial bought 3,701 Viking Therapeutics shares in Q1 2026, an estimated $119K.
  • Viking Therapeutics made up 0.01% of Stifel Financial's portfolio in Q1 2026, its #898 holding.
  • Stifel Financial first reported a position in Viking Therapeutics in Q2 2018 and has held it in 24 quarters since.
  • Stifel Financial's Viking Therapeutics position peaked at $11.8M in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.